Veterinary Pain Management Market

Veterinary Pain Management Market - By Product (Drug [NSAID, Opioid], Device [Laser, Electromagnetic]), By Application (Joint Pain, Cancer, Postoperative), By Animal (Companion, Livestock), By End-user (Hospital, Clinic) & Global Forecast, 2024-2032

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Veterinary Pain Management Market Size

Estimated to be USD 1.7 billion in 2023, the veterinary pain management market is predicted to grow at a CAGR of 7.1%. By 2032 it will have expanded. Key elements driving this market include the growing number of pet owners, increasing frequency of animal ailments, increasing animal medicalization rate, increasing acceptance of pet insurance, and growing popularity of laser treatment in pain management.

To get key market trends

  Download Free Sample

Veterinary practitioners that perform pain management provide themselves with the knowledge required to identify and control pain in many different kinds of big, small, and unusual animals. Many disorders, including cancer, arthritis, and surgical operations, can cause pain; among the available treatments are laser therapy, prescription medicines, therapeutic massages, complementary therapies, and electromagnetic treatment.

Veterinary Pain Management Market Report Attributes
Report Attribute Details
Base Year 2022
Veterinary Pain Management Market Size in 2022 USD 1.6 Billion
Forecast Period 2023 to 2032
Forecast Period 2023 to 2032 CAGR 7.1%
2032 Value Projection USD 3.2 Billion
Historical Data for 2018 to 2022
No. of Pages 327
Tables, Charts & Figures 591
Segments covered Product, Applications, Animal Type, End-user, and Region
Growth Drivers
  • Rising number of pet owners
  • Growing prevalence of animal diseases
  • Increasing adoption of pet insurance
  • Growing animal medicalization rate
  • Rising adoption of laser therapy in pain management
Pitfalls & Challenges
  • High pet care costs
  • Shortage of skilled professionals

What are the growth opportunities in this market?

 Download Free Sample

Rising preventive care and treatment facilities for companion animals, more acceptance of non-pharmaceutical and non-traditional treatment modalities, veterinary service adoption, and rising animal healthcare expenditure will all help to drive a growth in the animal drugs market including pain management therapeutics.

Covid-19 Impact

Particularly in 2020, the veterinary pain management market suffered with the COVID-19 epidemic. Lockdowns in several nations caused this detrimental effect mostly by closing businesses and limiting access to veterinary treatment. Due to the closure and forced closing of veterinary hospitals and clinics, this fact has caused obstacles for pets to get veterinary treatments for their dear companions. Furthermore, the epidemic presented significant difficulties for veterinary hospitals and clinics since the risk of disease spread in facilities and natural surroundings.

Maintaining a safe distance from their animals is also advised of pet owners to guarantee hygiene and lower their danger of contamination. Among the most affected sectors are those of cattle and associated businesses. This is mostly explained by the restrictions of animal mobility and the availability decline of production inputs. Conversely, the higher acceptance of pets during the lockdown raised demand for veterinary products including painkillers.

Following the epidemic, the market is beginning to pick up steam and should keep rising over the next years. Rising pet population, growing animal health spending, and changes in pet insurance uptake are supposed to drive the market expansion.

Market regions

Veterinary Pain Management Market Trends

Veterinary pain management is the medical method utilized in the prevention, diagnosis, and treatment of pain resulting from numerous causes, including physical trauma, internal organ disorders, surgical operations, spine difficulties, arthritis, and joint damage.

One of the main elements driving the expansion of the market is rising incidences of infectious diseases and growing consciousness and diagnosis concerning deficient diseases, genetic diseases, and physiological disorders in animals all around the world. Veterinary treatment and the quality of life of animals depend definitely on the interactions between pet owners and their animals. Veterinary medicine is predicted to be adopted more as people embrace pets in tandem with rising knowledge of their health issues.

Another crucial element supporting the expansion of the industry is increasing attention on the state of veterinary facilities and enhancing the general healthcare infrastructure. Rising number of public and private player strategic alliances concerning financing and deployment of innovative and advanced technologies is further generating profitable market prospects. Moreover, growing government campaigns to raise knowledge of the need of early diagnosis are once more supporting the rate of market growth.

Veterinary Pain Management Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on product, the veterinary pain management market is segmented into drugs and devices. Drugs segment accounted for the largest market share in terms of revenue in 2022. .  The veterinary pain management drugs are more widely used and cost-effective. Drugs are able to treat a wide variety of diseases and are more easily available, and also, they are convenient to administer in certain scenarios compared to devices. The drugs are further subsegmented into NSAIDS, opioids, anesthetics, alpha-2 agonists, and other drugs.

Companies are trying to develop new NSAIDs with lesser adverse effects and reactions. For instance, in January 2022, the U.S. FDA approved Zorbium (buprenorphine transdermal solution), the first transdermal buprenorphine animal medication for post-surgical pain management in cats.

When it comes to treating pets with pain, veterinarians have different types of pain management treatments for different kinds of issues. These include joint pain, cancer pain, and pain after surgery. Joint pain is the most common type of pain that vets treat. This is because a lot of pets, especially dogs, get arthritis and other problems with their bones and muscles. For example, a study showed that 1 in 5 dogs will have hip and joint problems at some point in their lives. This can make it hard for them to move and play, and it can make them feel uncomfortable. Pet owners often worry about their pet's joint pain, which makes them more likely to seek treatment for it, leading to a bigger market for joint pain treatments.

Learn more about the key segments shaping this market

 Download Free Sample

Based on animal type, the veterinary pain management market is segmented into companion animals and livestock animals. The companion animal segment accounted for the largest revenue share in 2022 owing to increase in their ownership, awareness regarding better pet care, demand for efficient animal care, and high animal healthcare spending in developing countries.

By end-user, the market is segmented into veterinary hospitals, veterinary clinics, retail pharmacies, and online pharmacies. The veterinary hospitals segment dominated the market and accounted for the largest market share of 43.8% in 2022. This is owing to a growing number of veterinary hospitals globally with advanced infrastructures.

Veterinary hospitals are very crucial for veterinary pain management as they provide professional therapies.

North America region

Veterinary Pain Management Market Share

The key veterinary pain management market players include

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Norbrook
  • Ceva Santé Animale
  • Dechra Pharmaceuticals
  • Vetoquinol Inc
  •  Alivira Animal Health Limited
  • Chanelle Pharma
  • K-Laser USA
  • Multi Radiance Medical

Market players adopt and implement various strategies, such as product launches, collaborations, expansions, and mergers. For instance, in October 2021, Summus Laser introduced “Horizon Veterinary Laser System,’’ a Class IV laser therapy system designed specifically for veterinary pain management. It is a diode-based laser with 28-watt power and has the unique capability of combining four different wavelengths, which can be controlled independently as well.

Veterinary Pain Management Regional Segmentation

Looking for region specific data?

 Download Free Sample

North America is expected to dominate the overall veterinary pain management market over the forecast period. The growth is due to factors such as rising pet adoption, increasing adoption of pet insurance, increasing awareness about pet’s health among pet owners, and the increasing animal healthcare expenditure in the region. The rise in the prevalence of various animal diseases and injuries has been identified as the major factor fuelling the market's rise.

Veterinary pain management market news

  • In September 2022, Zoetis launched Solensia to manage feline osteoarthritis pain in the United States.
  • In April 2022, The U.S. FDA has approved medetomidine and vatinoxan hydrochlorides injection (Zenalpha) for use as a sedative and analgesic in dogs, while undergoing certain clinical examination and procedures, and minor surgical procedures.
  • In January 2018, Dechra Pharmaceuticals acquired Le Vet and Ast Farma in a probe to expand its business in the Netherlands and Europe. this partnership was focused on launch of new product, Tralieve (a pain relief tablet), in Germany, the UK, and France.

The veterinary pain management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product

  • Drugs
  • Drug type
    • NSAIDS
    • Opioids
    • Anesthetics
    • Alpha-2 agonists
    • Other drugs
  • Route of administration
    • Oral
    • Parenteral
    • Topical 
  • Devices
  • Laser therapy
  • Electromagnetic therapy

By Application

  • Joint Pain
  • Osteoarthritis
  • Musculoskeletal disorders 
  • Cancer
  • Postoperative pain
  • Other applications

By Animal Type

  • Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
  • Livestock animals
  • Cattel
  • Swine
  • Other livestock animals

By End-user

  • Veterinary hospitals
  • Veterinary clinics
  • Retail pharmacies
  • Online pharmacies

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe          
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific 
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific   
  • Latin America       
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa        
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa
       

Table of Content

  • Introduction
    1.1 Market Overview
    1.2 Definition and Scope
    1.3 Market Dynamics
        1.3.1 Drivers
        1.3.2 Restraints
        1.3.3 Opportunities
    1.4 Research Methodology

  • Market Segmentation by Type
    2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    2.2 Opioids
    2.3 Local Anesthetics
    2.4 Corticosteroids
    2.5 Others (Adjunct Therapies, Nutraceuticals)

  • Market Segmentation by Application
    3.1 Companion Animals (Dogs, Cats, etc.)
    3.2 Livestock Animals (Cattle, Sheep, Pigs, etc.)
    3.3 Equine
    3.4 Others (Exotics, Wildlife)

  • Key Players and Competitive Landscape
    4.1 Company Profiles
        4.1.1 Zoetis Inc.
        4.1.2 Elanco Animal Health
        4.1.3 Boehringer Ingelheim
        4.1.4 Dechra Pharmaceuticals
        4.1.5 Merck Animal Health
        4.1.6 Other Key Players

  • Regional Analysis
    5.1 North America
    5.2 Europe
    5.3 Asia-Pacific
    5.4 Latin America
    5.5 Middle East & Africa

  • Market Trends and Future Outlook
    6.1 Emerging Technologies in Veterinary Pain Management
    6.2 Regulatory Landscape
    6.3 Market Forecast (2023-2030)

  • Conclusion and Recommendations

  • Appendix
    8.1 Abbreviations
    8.2 Sources and References

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.